Yang, La-Wei <br/><br/>
miR-155 increases stemness and decitabine resistance in triple-negative breast cancer cells by inhibiting TSPAN5.  [electronic resource] 

 -  Molecular carcinogenesis  04 2020 
 - 447-461 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-2744 
<br/><br/><label>Standard No.: </label>10.1002/mc.23167  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimetabolites, Antineoplastic--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Decitabine--pharmacology<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Gene Knockdown Techniques<br/>Humans<br/>MicroRNAs--genetics<br/>Neoplastic Stem Cells--metabolism<br/>Signal Transduction--drug effects<br/>Tetraspanins--genetics<br/>Triple Negative Breast Neoplasms--genetics